CMAP Software
CMAP Software is an integrated project management system specifically designed for MedComms agencies.
Key Features:
– CRM
– JOb Costing
– Resourcing
– Invoicing
– Business and Financial Reports
– MSA tracking
– KAM profiles
CMAP has been designed to fit the needs MedComms agencies in digital, medical writing, pharmacovilgence, market access, health economics, research, education and life sciences.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…
Nmblr
From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.
Company Details
Latest Content from PMHub
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Press Releases | June 23, 2026 | Medscape Education
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...
Designing Pharma Stands That People Actually Want to Step Onto
Press Releases | June 18, 2026 | Apex Events and Exhibitions
Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a stand that invites meaningful engagement...
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
White Papers and Resources | June 18, 2026 | Inizio
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
The solution: Good localisation doesn’t feel translated
White Papers and Resources | June 18, 2026 | Cuttsy + Cuttsy
Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.
Good Patient Partnership Guide 2026: Patient Journey Mapping with the Patient Community
White Papers and Resources | June 18, 2026 | Precision AQ
Patient insight gathering and journey mapping can inform and enhance decision making and initiatives across life sciences. The Good Patient Partnership Guide 2026 brings together practical guidance, real world examples...
Healthcare information is becoming easier to access. Trust isn’t.
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.
It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment
White Papers and Resources | June 17, 2026 | Cuttsy + Cuttsy
ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
Press Releases | June 17, 2026 | Uniphar
Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial TOKYO, Japan and DUBLIN, Ireland — [June 16, 2026] J‑Pharma Co., Ltd., a clinical-stage biotechnology...
Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education
Press Releases | June 16, 2026 | Medscape Education
Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award for its PIONEER initiative in...
How to build a commercialisation strategy fit for biopharma’s new evidence era
White Papers and Resources | June 11, 2026 | Nmblr
The bar for evidence has never been higher. The EU's Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across member states. Regulators are demanding...